Nom du produit:1-Methyl-1H-pyrazole-4-sulfonyl chloride

IUPAC Name:1-methyl-1H-pyrazole-4-sulfonyl chloride

CAS:288148-34-5
Formule moléculaire:C4H5ClN2O2S
Pureté:95%+
Numéro de catalogue:CM188010
Poids moléculaire:180.61

Unité d'emballage Stock disponible Prix($) Quantité
CM188010-10g in stock ǪǙů
CM188010-25g in stock ľǪƥ
CM188010-100g in stock ŗŗƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:288148-34-5
Formule moléculaire:C4H5ClN2O2S
Point de fusion:-
Code SMILES:O=S(C1=CN(C)N=C1)(Cl)=O
Densité:
Numéro de catalogue:CM188010
Poids moléculaire:180.61
Point d'ébullition:
N° Mdl:MFCD04968667
Stockage:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Relacorilant
Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.